315 results
Page 3 of 16
8-K
EX-99.1
z8r 427s55y
5 Aug 21
Windtree Therapeutics Reports Second Quarter 2021 Financial Results and Provides Key Business Updates
5:31pm
8-K
EX-99.1
i63ayakb9oelovdx3 55
13 May 21
Windtree Therapeutics Reports First Quarter 2021 Financial Results and Provides Key Business Updates
7:34am
8-K
EX-99.1
yw45mj 2j
29 Mar 21
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
5:26pm
8-K
EX-1.1
5smijjwivnu
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
424B5
a0hr odktow91if7
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
aj2vsywv105rwp
22 Mar 21
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.1
ew0oo9zu
16 Nov 20
Windtree Therapeutics Reports Third Quarter 2020
7:40am
8-K
EX-99.1
i09p0udukhuup3kvf8t
1 Oct 20
Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
7:36am
8-K
EX-99.1
97bo56 t32
29 Sep 20
Other Events
7:37am
8-K
EX-99.1
1w4v8xjxsizkc439y1
14 Aug 20
Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
6:07am
8-K
EX-99.1
bz9y9iwge2fhfkf
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-99.2
vz24h7wueejzr5 qyfb
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm